Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dar Savanna is a Riyadh-based biotechnology company and innovation hub established by Flagship Pioneering to accelerate the development of breakthrough life science technologies in the Middle East. Launched in 2024 through a strategic partnership with the Saudi Ministry of Investment and the Public Investment Fund (PIF), the company applies Flagship's bioplatform venture creation model to address unmet medical needs and sustainability challenges. Dar Savanna serves as a regional center for scaling Flagship’s portfolio companies and fostering a local ecosystem for genomic medicine, agriculture, and food security. The initiative is a core component of Saudi Arabia's Vision 2030, aiming to position the Kingdom as a global leader in biotechnology. By integrating local talent with global expertise, Dar Savanna seeks to transform the regional healthcare landscape through innovative therapeutic and diagnostic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dar Savanna.